PFAS Chemicals: With Regulatory and Litigation Tides Rising, Lessons from Past Mass-Tort Battles
news | July 22, 2019Firm partner Frank Leone on PFAS for Legal Newsline.
In Law360’s 2019 Glass Ceiling Report, “The Best Law Firms for Female Attorneys,” Hollingsworth LLP is ranked in the top 10 of all midsize firms (50-149 attorneys). We are pleased that our long-standing efforts to recruit…
Joining List of Impressive Honorees, Longtime Firm Client, Tom Kendris of Novartis, Receives Atlantic Legal Foundation Annual Award
news | January 3, 2019Atlantic Legal Foundation is the preeminent organization fostering sound science in American jurisprudence.
Eric Lasker participates in roundtable discussion sponsored by the Judicial Conference Advisory Committee on Rules of Evidence.
news | October 4, 2018In keeping with Hollingsworth LLP’s long-proven commitment to advancing the letter and spirit of Daubert and FRE 702, Firm partner Eric Lasker participated in October 2018 in a roundtable discussion on a potential amendment to FRE…
Joe Hollingsworth Serving on Steering Committee for DePauw University’s Rector Scholarship Centennial.
news | October 1, 2018Firm founder Joe G. Hollingsworth is serving as a member of the Steering Committee for DePauw University’s Rector Scholarship Centennial. 2019 marks the centennial year of Edward and Lucy Rowland Rector’s historic scholarship gift in 1919,…
Hollingsworth LLP named 2018 U.S.Complex Litigation Law Firm of the Year and 2018 U.S.Pharmaceutical Products Liability Law Firm of the Year
news | June 21, 2018The ACQ5 2018 Global Awards have been announced and Hollingsworth LLP is honored to have been selected as the Complex Litigation and Pharmaceutical Products Liability Law Firm of the Year in the U.S. The awards launched…
On June 12, 2018, the Fourth Circuit unanimously affirmed a decision excluding expert causation testimony and granting summary judgment in favor of Pfizer on claims that its drug Lipitor can cause diabetes. In re: Lipitor (Atorvastatin…
To support our implementation of an array of attorney development initiatives, Hollingsworth LLP has joined the Diversity & Flexibility Alliance, a community of industry leaders at law firms, professional services firms, and corporations dedicated to flex…
Hollingsworth LLP represents Monsanto in In Re:Roundup Products Liability Litigation in the Northern District of California.
Third Circuit Agrees with Hollingsworth LLP Amicus Brief in Zoloft Case, Affirming Exclusion of Causation Expert
news | June 2, 2017In June 2017, the 3rd Circuit unanimously affirmed a decision excluding expert causation testimony and granting summary judgment in favor of Pfizer on claims that its anti-depressant drug Zoloft can cause cardiac birth defects if taken…
Firm partner Eric Lasker represented DynCorp at jury trial in U.S. District Court for the District of Columbia.
In Reclast case, Novartis obtains summary judgment based on Daubert exclusion of causation experts’ testimony.
news | February 10, 2017February 2017 — Hollingsworth LLP flexed its considerable Daubert muscle once again in serial pharma litigation in Jones v Novartis. With the benefit of extensive briefing by Firm partners Stephen A. Klein and Robert E. Johnston, and…
Donald W. Fowler Named an “Environmental Lawyer of the Year” by Corporate Livewire
news | January 13, 2017Firm partner, Don Fowler, has been named to the 2017 “Environmental Lawyer of the Year” list by Corporate LiveWire‘s M&A Awards. The awards recognize individuals that have consistently shown best practice and demonstrated general excellence throughout…
Hollingsworth LLP filed amicus brief in support of mobile phone makers in significant DC Court of Appeals victory.
news | November 7, 2016The Firm and the U.S. Chamber of Commerce filed a business coalition amici curiae brief supporting the mobile phone industry.